Biomarin Pharmaceutical (BMRN) Gross Margin (QoQ) (2009 - 2026)

Biomarin Pharmaceutical (BMRN) Gross Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Biomarin Pharmaceutical 11.33 Bn 9.11 Bn 571.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 608.00
Dec 31, 2025 -1,348.00
Sep 30, 2025 13.00
Jun 30, 2025 216.00
Mar 31, 2025 -212.00
Dec 31, 2024 705.00
Sep 30, 2024 -695.00
Jun 30, 2024 97.00
Mar 31, 2024 205.00
Dec 31, 2023 68.00
Sep 30, 2023 -8.00
Jun 30, 2023 77.00
Mar 31, 2023 457.00
Dec 31, 2022 -427.00
Sep 30, 2022 5.00
Jun 30, 2022 -54.00
Mar 31, 2022 410.00
Dec 31, 2021 -129.00
Sep 30, 2021 0.00
Jun 30, 2021 -60.00